Unlocking the Potential of CALML3: A Calcium-Homeostasis Regulator as a Drug Target and Biomarker

Target Name: CALML3

NCBI ID: G810

CALML3

Unlocking the Potential of CALML3: A Calcium-Homeostasis Regulator as a Drug Target and Biomarker

Calcium homeostasis plays a critical role in various physiological processes, including muscle contractions, nerve function, and brain development. Imbalances in calcium levels can lead to a range of disorders, including muscle weakness, paralysis, and even cardiac arrhythmias. The protein NB-1, also known as CALML3, has been identified as a key regulator of calcium homeostasis. In this article, we will explore the potential of CALML3 as a drug target and biomarker.

The NB-1 gene and its function

The NB-1 gene is located on chromosome 16 and encodes a protein known as NB-1. NB-1 is a 21-kDa protein that plays a critical role in regulating calcium homeostasis. It is a key regulator of the intracellular calcium concentration and is involved in various physiological processes, including muscle contractions, nerve function, and blood clotting.

The NB-1 gene is expressed in many tissues and cells, including muscle, nerve, heart, and blood vessels. It is also highly expressed in the brain, where it is involved in the development and maintenance of neural circuits. NB-1 has been shown to play a role in modulating neurotransmitter release, neuropeptide synthesis, and intracellular signaling pathways.

In addition to its role in neurotransmission, NB-1 is also involved in the regulation of calcium homeostasis. It has been shown to play a critical role in the regulation of intracellular calcium concentration and has been shown to interact with several other proteins involved in calcium homeostasis, including calbindin, parvalbumin, and TRPV2.

The potential of NB-1 as a drug target

The potential of NB-1 as a drug target is due to its unique mechanism of action and its involvement in various physiological processes. One of the key advantages of NB-1 is its ability to modulate intracellular calcium concentration, making it an attractive target for drugs that aim to regulate calcium homeostasis.

There is a growing body of research that suggests that alterations in intracellular calcium concentration can contribute to a range of disorders, including chronic pain, anxiety, and neurodegenerative diseases. NB-1 has been shown to play a role in modulating intracellular calcium concentration, which suggests that it may be a useful target for drugs that aim to regulate calcium homeostasis.

In addition to its potential as a drug target, NB-1 also has the potential as a biomarker. The NB-1 gene has been shown to be involved in the regulation of various physiological processes, including muscle contractions and nerve function. By using techniques such as qRT-PCR, RNA sequencing, and immunohistochemistry, researchers have been able to detect and quantify NB-1 expression in various tissues and cells.

The potential of NB-1 as a biomarker for certain diseases

The potential of NB-1 as a biomarker for certain diseases is due to its involvement in various physiological processes that are affected by changes in intracellular calcium concentration. For example, alterations in intracellular calcium concentration have been implicated in a range of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In addition to its potential as a drug target and biomarker, NB-1 is also an attractive target for research into the role of calcium homeostasis in disease. Further studies are needed to fully understand the role of NB-1 in modulating intracellular calcium concentration and its potential as a drug target and biomarker for various diseases.

Conclusion

In conclusion, the protein NB-1, also known as CALML3, has a unique mechanism of action and is involved in various physiological processes that are affected by changes in intracellular calcium concentration. As a result, it has the potential to be a drug target and biomarker for a range of diseases. Further research is needed to fully understand the role of NB-1 in modulating intracellular calcium concentration and its potential as a drug target and biomarker for various diseases.

Protein Name: Calmodulin Like 3

Functions: May function as a specific light chain of unconventional myosin-10 (MYO10), also enhances MYO10 translation, possibly by acting as a chaperone for the emerging MYO10 heavy chain protein. May compete with calmodulin by binding, with different affinities, to cellular substrates

The "CALML3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CALML3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets